| Bioactivity | Cbl-b-IN-8 (Compound 293) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.5 nM and 7.8 nM, respectively[1]. |
| Target | IC50: 5.5 nM (Cbl-b), 7.8 nM (c-Cbl) |
| Name | Cbl-b-IN-8 |
| CAS | 2815223-33-5 |
| Formula | C35H44F3N7O3 |
| Molar Mass | 667.76 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jun Liang, et al. Lactams as cbl-b inhibitors. Patent WO2022169997A1. |
Cbl-b-IN-8
CAS: 2815223-33-5 F: C35H44F3N7O3 W: 667.76
Cbl-b-IN-8 (Compound 293) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.5 nM and 7.8 nM,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.